These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 336410)

  • 41. On the inhibition of gluconeogenesis by biguanides in the perfused guinea pig liver.
    Haeckel R; Haeckel H
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):288-9. PubMed ID: 5420695
    [No Abstract]   [Full Text] [Related]  

  • 42. Uncoupling effect of hypoglycemic sulphonylureas on the isolated rat liver mitochondria.
    Katsumata K; Hagihara M
    Nagoya J Med Sci; 1973 Mar; 35(2):141-50. PubMed ID: 4269965
    [No Abstract]   [Full Text] [Related]  

  • 43. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the use of oral antidiabetic drugs].
    Aarseth S
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1595-601. PubMed ID: 4588815
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 46. [Physiologic and physiopathologic implications of insulin-receptor interaction (II). Pathologic situations in which changes in insulin-receptor interaction are detected].
    Durán García S; Hernández Herrero C
    Med Clin (Barc); 1984 Apr; 82(14):639-45. PubMed ID: 6376967
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical pharmacology of oral hypoglycemic drugs].
    Tatoń J
    Pol Tyg Lek; 1968 Sep; 23(34):1289-92. PubMed ID: 5722532
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Oral antidiabetics].
    Bally C; Assal JP
    Ther Umsch; 1979 Nov; 36(11):1000-3. PubMed ID: 538739
    [No Abstract]   [Full Text] [Related]  

  • 50. Interference of sulphonylurea antidiabetica with mitochondrial bioenergetics under in vivo conditions.
    Somogyi J; Vér A; Trója G; Végh E; Bányász T; Csermely P; Popović S; Kovács T
    Acta Physiol Hung; 1995; 83(4):313-21. PubMed ID: 8863894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes].
    Valdés R E; Soto-Chacón E; Lahsen M R; Barrera H C; Candía P P
    Rev Med Chil; 2008 Jul; 136(7):915-20. PubMed ID: 18949170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pitfalls in treatment with oral antidiabetic agents].
    Perusicová J
    Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Plasmatic vehiculization of insulin in comparison with oral hypoglycemic agents].
    Lenti G; Pagano G
    Minerva Med; 1972 Mar; 63(18):1044-9. PubMed ID: 5016062
    [No Abstract]   [Full Text] [Related]  

  • 55. The in vitro effect of two oral hypoglycemic agents on hepatic protein synthesis.
    DeChatelet LR; McDonald HJ
    Proc Soc Exp Biol Med; 1966 Jul; 122(3):765-8. PubMed ID: 5918947
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative study of the effect of a principle extracted from Eugenia Jambolana bark with NN-methyldimethyl biguanide and glybutamide on induced hypoglycemia in normal rats].
    Ratsimamanga AR; Lefournier-Contensou C; Bibal-Prot P
    C R Acad Hebd Seances Acad Sci D; 1972 Aug; 275(8):913-5. PubMed ID: 4628567
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of the action of hypoglycemia-producing biguanide and sulfonylurea compounds on oxidative phosphorylation.
    FALCONE AB; MAO RL; SHRAGO E
    J Biol Chem; 1962 Mar; 237():904-9. PubMed ID: 13891416
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition by diphenyleneiodonium and by some of its substituted derivatives of gluconeogenesis in isolated rat hepatocytes.
    Gatley SJ; Al-Bassam SS; Taylor JR; Sherratt HS
    Biochem Soc Trans; 1975; 3(2):333-5. PubMed ID: 165996
    [No Abstract]   [Full Text] [Related]  

  • 59. Rat liver glycogen-lowering activity of fed creatine--a retraction.
    Laastuen L; Todd WR
    J Nutr; 1969 Dec; 99(4):446-8. PubMed ID: 5361587
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of the oral hypoglycemic agent, pirogliride, on gluconeogenesis.
    Tutwiler GF; Brentzel HJ
    Biochem Pharmacol; 1980 May; 29(10):1421-7. PubMed ID: 7396976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.